135 gastric cancers (GC) patients who were treated with epirubicin, cisplatin and 5-FU adjuvant chemotherapy (ECF) following surgical resection and explored their potential clinical significance...The Kaplan-Meier survival analysis revealed a higher ATG-5 expression was significantly associated with poorer OS (P<0.001) and DFS (Pā=ā0.003).